Table 2.

Prescribing preferences in non-secluded and secluded patients

Drug	Non-secluded patients						Secluded patients
	Rank 1		Rank 2		Rank 3		Rank 1		Rank 2		Rank 3
	Frequency	%	Frequency	%	Frequency	%	Frequency	%	frequency	%	Frequency	%
Alprazolam	2	1.9			5	4.6	1	0.9	1	0.9	4	3.7
Alprazolam (LA)					1	0.9
Amisulpiride											1	0.9
Aripiprazole	3	2.8	1	0.9	3	2.8	4	3.7			1	0.9
Bromazepam			1	0.9							1	0.9
Clonazepam					1	0.9					2	1.9
Clorazepaat	4	3.7	5	4.6	7	6.5	4	3.7	6	5.6	7	6.5
Clotiapine	21	19.4	8	7.4	14	13	23	21.3	13	12.0	11	10.2
Cloxazolam									1	0.9
Diazepam	5	4.6	10	9.3	5	4.6	6	5.6	15	13.9	5	4.6
Droperidol	7	6.5	13	12	8	7.4	16	14.8	12	11.1	11	10.2
Escitalopram			1	0.9	1	0.9
Haloperidol	7	6.5	3	2.8	10	9.3	4	3.7	7	6.5	13	12.0
Lamotrigine											1	0.9
Lorazepam	23	21.3	23	21.3	12	11.1	14	13	24	22.2	14	13
Midazolam	2	1.9	2	1.9	2	1.9	2	1.9	3	2.8	2	1.9
Olanzapine	24	22.2	19	17.6	12	11.1	23	21.3	12	11.1	8	7.4
Paliperidone					1	0.9					1	0.9
Pipamperone			3	2.8	1	0.9			2	1.9
Prazepam					1	0.9					1	0.9
Promethazin			1	0.9					1	0.9	3	2.8
Quetiapine	5	4.6	12	11.1	5	4.6	3	2.8	6	5.6	3	2.8
Risperidone	2	1.9	2	1.9	3	2.8			1	0.9	2	1.9
Trazodone			1	0.9
Sodium valproate	1	0.9			4	3.7	1	0.9			2	1.9
zuclopenthixol					3	2.8					4	3.7
zuclopenthixol (LA)	2	1.9	3	2.8	9	8.3	7	6.5	4	3.7	11	10.2
Total	108	100	108	100	108	100	108	100	108	100	108	100

LA long acting.